Skip to content

Study · Animal study (in vivo) · mouse · 1995

1 result

Induction of c-fos mRNA in the arcuate nucleus of normal and mutant growth hormone-deficient mice by a synthetic non-peptidyl growth hormone secretagogue.

Sirinathsinghji DJ, Chen HY, Hopkins R, Trumbauer M, Heavens R, Rigby M, Smith RG, van der Ploeg LH

Neuroreport1 Oct 1995Cited by 10 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Mechanism

    In control and mutant mice, GHRP‑6 induced marked c-fos mRNA expression in the arcuate-ventromedial hypothalamus.

    In plain wordsIn control and mutant mice, GHRP‑6 increased c-fos mRNA expression in the arcuate-ventromedial hypothalamus.

    Peptide
    GHRP-6
    Outcome
    IncreaseHypothalamic c-fos mRNA expression
    Study

    mousen: not reported in source

    Wild-type, dwarf and little mutant mice
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    Dose not stated · systemic injectionAs given in this study (mouse).

    Source sentences

    Summary
    Both GH secretagogues induced a marked c-fos mRNA expression in the arcuate-ventromedial hypothalamus (ARC-VMH) of both control and mutant mice indicating a possible action on growth hormone releasing hormone (GHRH) neurones in the ARC-VMH.
    1 context sentence
    Summary · context
    We have studied by in situ hybridization histochemistry the mRNA expression of the c-fos immediate early gene in the brains of wild type and dwarf(dw/dw) and little(lit/lit) mutant mice after systemic injections of the synthetic GH secretagogues GHRP-6 and L-163,191.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 2

    14 Oct 2026, 01:46 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.